BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  Anavex Life Sciences Corp. CEO to Present Clinical Prediction Data for ANAVEX 2-73 at CNS Summit 2013

  November 7, 2013

   · 

  2 min read
• Business

  Bioren, Inc. Reports $505,000 in Earnings for the Nine Months Ended September 30, 2013

  November 7, 2013

   · 

  2 min read
• Business

  NxStage Medical, Inc. Reports Third Quarter 2013 Financial Results

  November 7, 2013

   · 

  1 min read
• Biotech Beach

  Volcano Corporation Presentation at Canaccord Genuity Conference to be Webcast

  November 7, 2013

   · 

  1 min read
• Business

  Cyberonics Inc. to Report Fiscal Year 2014 Second Quarter Results and Host Webcast and Conference Call on November 21, 2013

  November 7, 2013

   · 

  1 min read
• FDA

  W. L. Gore & Associates, Inc. Release: GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its Kind Approved in Europe

  November 7, 2013

   · 

  1 min read
• Neovasc Inc., an OPKO Supported Company, Reports That Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Function in Patients with Refractory Angina

  November 7, 2013

   · 

  1 min read
• Pharm Country

  Rosetta Genomics Ltd. Granted U.S. Patent Allowance for the Use of microRNAs to Treat Liver Cancer

  November 7, 2013

   · 

  6 min read
• Pharm Country

  Integral Molecular, Inc. Announces Issuance of Third Patent Family, Extending Patent Landscape for Key Lipoparticle Technology

  November 7, 2013

   · 

  1 min read
• Business

  Alnylam Pharmaceuticals Reports Third Quarter 2013 Financial Results

  November 7, 2013

   · 

  1 min read